Adventist Health System West’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.5M Hold
1,131,440
12.86% 2
2025
Q4
$70.7M Hold
1,131,440
11.88% 2
2025
Q3
$67.8M Hold
1,131,440
11.04% 2
2025
Q2
$64.5M Hold
1,131,440
9.58% 3
2025
Q1
$57.5M Hold
1,131,440
9.08% 4
2024
Q4
$54.1M Hold
1,131,440
8.37% 5
2024
Q3
$59.8M Hold
1,131,440
9.19% 3
2024
Q2
$55.9M Buy
+1,131,440
New +$56.3M 9.08% 3

Other funds holding VEA

Adventist Health System West's VEA Position: Q1 2026 in Review

Adventist Health System West held its Vanguard FTSE Developed Markets ETF (VEA) position steady in Q1 2026 at 1,131,440 shares worth $72.5M. The position accounts for 12.86% of the portfolio, ranked #2.

Adventist Health System West first reported a position in VEA in Q2 2024 and has held it in 8 quarters since. 2,891 funds tracked by Wall St. Rank hold VEA as of Q1 2026.

  • Adventist Health System West held 1,131,440 shares of Vanguard FTSE Developed Markets ETF worth $72.5M as of Q1 2026.
  • Adventist Health System West left its Vanguard FTSE Developed Markets ETF share count unchanged in Q1 2026.
  • Vanguard FTSE Developed Markets ETF made up 12.86% of Adventist Health System West's portfolio in Q1 2026, its #2 holding.
  • Adventist Health System West first reported a position in Vanguard FTSE Developed Markets ETF in Q2 2024 and has held it in 8 quarters since.
  • 2,891 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.

Based on Adventist Health System West's 13F filing for Q1 2026, filed 12 May 2026.